Avançar para navegação principal
Avançar para pesquisar
Avançar para conteúdo principal
Ordenar por
Pharmacology, Toxicology and Pharmaceutical Science
Cytotoxicity
100%
Breast Cancer
68%
Malignant Neoplasm
51%
Nanoparticle
39%
Cosmetics
37%
Cell Viability
34%
Antioxidant
30%
Antioxidant Capacity
29%
Plectranthus
29%
Reactive Oxygen Metabolite
29%
Doxorubicin
27%
Neoplasm
27%
Ionic Liquid
24%
Antiinfective Agent
23%
Genotoxicity
21%
Superoxide Dismutase
21%
Non Small Cell Lung Cancer
19%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
19%
Antimicrobial Agent
18%
IC50
16%
Acrylamide
16%
Diseases
15%
Glycidamide
14%
Sunscreen
14%
Cisplatin
14%
Glutathione
13%
Kidney Cancer
13%
Porphyrin
12%
Deoxyribonuclease I
12%
Rutin
12%
Superoxide
11%
Protein Lysine 6 Oxidase
11%
Diterpene
11%
Renal Cell Carcinoma
11%
Choline
11%
Detoxication
11%
Triple Negative Breast Cancer
10%
Rosmarinic Acid
10%
Brain Metastasis
10%
Natural Product
10%
Systemic Treatment
9%
Photothermal Therapy
9%
Cuprous Ion
9%
Injury
9%
Macrocyclic Compound
9%
Gold Nanoparticle
9%
Fatty Acid
9%
Wheezing
9%
Volatile Organic Compound
9%
Virtual Screening
9%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
80%
Cell Migration
44%
Lysyl Oxidase
41%
Cytotoxicity
29%
Bioinformatics
26%
Cell Viability
22%
Anticancer
21%
Cell Invasion
17%
Doxorubicin
15%
Enzyme
15%
Cell Motility
15%
Cisplatin
14%
Porphyrin
12%
Oxidative Stress
12%
Clinical Trial
11%
IC50
10%
Trastuzumab
10%
Trastuzumab Emtansine
9%
Lapatinib
9%
Neratinib
9%
Medline
9%
Cell Fate
9%
Cell Adhesion
9%
Superoxide Dismutase
9%
LOXL1
9%
Elastin
9%
MMP2
9%
Gelatinase A
9%
Keratinocyte
9%
Hydrogen Peroxide
9%
DNA Damage
8%
Cross-Link
8%
Fibroblast
8%
Homeostasis
8%
Golgi Apparatus
7%
Gene Linkage
7%
Metabolic Pathway
7%
Chemotaxis
7%
Microtubule Assembly
6%
Ion Channel
6%
Pertuzumab
5%
Gallic Acid
5%
Antibacterial Activity
5%
Messenger RNA
5%
Metabolite
5%
Survival Rate
5%
Medicine and Dentistry
Cancer Cell
50%
Breast Cancer
44%
Cell Migration
35%
Cytotoxicity
25%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
24%
Non Small Cell Lung Cancer
19%
Reactive Oxygen Species
18%
In Vitro
17%
Cisplatin
14%
Wheeze
14%
Brain Metastasis
13%
Doxorubicin
12%
Metastatic Carcinoma
11%
Porphyrin
11%
Superoxide Dismutase
11%
Cell Motility
10%
Systemic Therapy
10%
Cell Viability
10%
Cell Invasion
10%
Volatile Organic Compound
9%
Disease
9%
Antioxidant
7%
Kidney Cancer
7%
Respiratory Disease
6%
Lung Cancer
6%
Cell Line
6%
Deoxyribonuclease I
6%
Neoplasm
6%
Cancer Therapy
5%
Polyphenol
5%
Cancer Growth
5%
Cross Sectional Study
5%
Malignant Neoplasm
5%
Gelatinase A
5%
Ganglioglioma
5%
Docetaxel
5%
Pertuzumab
5%
